Taufiqur Rahman Bhuiyan
Taufiqur Rahman Bhuiyan
Senior Scientist, icddr,b
Verified email at - Homepage
Cited by
Cited by
Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh
F Qadri, TF Wierzba, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, ...
New England Journal of Medicine 374 (18), 1723-1732, 2016
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial
F Qadri, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, YA Begum, ...
The Lancet 386 (10001), 1362-1371, 2015
Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut
F Qadri, TR Bhuiyan, KK Dutta, R Raqib, MS Alam, NH Alam, ...
Gut 53 (1), 62-69, 2004
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea
T Ahmed, TR Bhuiyan, K Zaman, D Sinclair, F Qadri
Cochrane Database of Systematic Reviews, 2013
Immune responses and protection in children in developing countries induced by oral vaccines
F Qadri, TR Bhuiyan, DA Sack, AM Svennerholm
Vaccine 31 (3), 452-460, 2013
Circulating Mucosal Associated Invariant T Cells Are Activated in Vibrio cholerae O1 Infection and Associated with Lipopolysaccharide Antibody Responses
DT Leung, TR Bhuiyan, NS Nishat, MR Hoq, A Aktar, MA Rahman, ...
PLoS neglected tropical diseases 8 (8), e3076, 2014
Broad up-regulation of innate defense factors during acute cholera
CF Flach, F Qadri, TR Bhuiyan, NH Alam, E Jennische, I Lönnroth, ...
Infection and immunity 75 (5), 2343-2350, 2007
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo …
F Qadri, M Akhtar, TR Bhuiyan, MI Chowdhury, T Ahmed, TA Rafique, ...
The Lancet Infectious Diseases 20 (2), 208-219, 2020
Histo–blood group antigen phenotype determines susceptibility to genotype-specific rotavirus infections and impacts measures of rotavirus vaccine efficacy
B Lee, DM Dickson, AC deCamp, E Ross Colgate, SA Diehl, MI Uddin, ...
The Journal of infectious diseases 217 (9), 1399-1407, 2018
Immunologic Responses to Vibrio cholerae in Patients Co-Infected with Intestinal Parasites in Bangladesh
JB Harris, MJ Podolsky, TR Bhuiyan, F Chowdhury, AI Khan, ...
PLoS neglected tropical diseases 3 (3), e403, 2009
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh
T Shirin, TR Bhuiyan, RC Charles, S Amin, I Bhuiyan, Z Kawser, A Rahat, ...
International Journal of Infectious Diseases 101, 220-225, 2020
Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
HC De Oliveira, MC Monteiro, SA Rossi, J Pemán, A Ruiz-Gaitán, ...
Frontiers in cellular and infection microbiology 9, 83, 2019
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial
F Qadri, M Ali, J Lynch, F Chowdhury, AI Khan, TF Wierzba, JL Excler, ...
The Lancet Infectious Diseases 18 (6), 666-674, 2018
Single-cell analysis of the plasmablast response to Vibrio cholerae demonstrates expansion of cross-reactive memory B cells
RC Kauffman, TR Bhuiyan, R Nakajima, LM Mayo-Smith, R Rashu, ...
MBio 7 (6), 10.1128/mbio. 02021-16, 2016
Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country
A Lundgren, TR Bhuiyan, D Novak, J Kaim, A Reske, YJ Lu, F Qadri, ...
Vaccine 30 (26), 3897-3907, 2012
Infection by Helicobacter pylori in Bangladeshi children from birth to two years: relation to blood group, nutritional status, and seasonality
TR Bhuiyan, F Qadri, A Saha, AM Svennerholm
The Pediatric infectious disease journal 28 (2), 79-85, 2009
Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera
CN Ellis, RC LaRocque, T Uddin, B Krastins, LM Mayo-Smith, D Sarracino, ...
Infection and immunity 83 (3), 1089-1103, 2015
A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain …
MA Sayeed, MK Bufano, P Xu, G Eckhoff, RC Charles, MM Alam, ...
PLoS neglected tropical diseases 9 (7), e0003881, 2015
LPLUNC1 modulates innate immune responses to Vibrio cholerae
OS Shin, T Uddin, R Citorik, JP Wang, P Della Pelle, RL Kradin, ...
Journal of Infectious Diseases 204 (9), 1349-1357, 2011
Estimating cholera incidence with cross-sectional serology
AS Azman, J Lessler, FJ Luquero, TR Bhuiyan, AI Khan, F Chowdhury, ...
Science translational medicine 11 (480), eaau6242, 2019
The system can't perform the operation now. Try again later.
Articles 1–20